ResultsIQ

ResultsIQ › Latest results › Religare Enterprises Limited

Religare Enterprises Limited Q2 FY27 results deck summary

NSE: RELIGARE · BSE: 532915

Results deck of 12 Nov 2026, summarised by AI from the filing.

Religare's Q2 FY27 consolidated loss before tax was ₹(127.79) cr as Care's combined ratio rose to 111.1% and Religare Finvest restarted lending on 6 Nov 2026.

Key takeaways

  1. No guidance The presentation gives no forward revenue, margin or profit guidance for FY27 or beyond.
  2. Finvest restart Religare Finvest restarted lending on 6 Nov 2026 with tangible net worth of ₹962.6 cr and zero GNPA/NNPA.
  3. Care growth Care's H1 FY27 GWP on n basis grew 35.1% YoY to ₹6,897 cr, led by retail health growth of 43.5%.
  4. Care margin Care's Q2 FY27 combined ratio rose to 111.1% from 107.7%, and profit before tax turned to ₹(124) cr.

Original filing on BSE

Religare Enterprises Limited Q2 FY27 results

As filed: Revenue ₹2,381 cr (+15% year on year), EBITDA −₹92.5 cr (−252% year on year), PAT −₹97.7 cr (−300% year on year), EBITDA margin -3.9% (−683 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹2,353 cr (+26% year on year), EBITDA −₹49.1 cr (−300% year on year), PAT −₹47.0 cr (−300% year on year), EBITDA margin -2.1% (−294 bps). Score 20 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 294 bps year on year. Revenue fell 5% from last quarter. Share price after the results: +8.1% in 30 days (Nifty 500: −3.4%).
  • Q4 FY26: Revenue ₹2,467 cr (+22% year on year), EBITDA ₹143 cr (−39% year on year), PAT ₹95.7 cr (−37% year on year), EBITDA margin 5.8% (−566 bps). Score 47 of 100, In line with trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was below it. EBITDA margin fell 566 bps year on year. Share price after the results: +4.0% in 30 days (Nifty 500: −0.8%).
  • Q3 FY26: Revenue ₹2,056 cr (+24% year on year), EBITDA −₹94.9 cr, PAT −₹76.5 cr, EBITDA margin -4.6% (−65 bps). Score 15 of 100, Below trend. Revenue growth was above the company's own trend. EBITDA margin fell 65 bps year on year. Profit fell 266% from last quarter. Revenue rose ₹392 cr on a year ago, more than the ₹153 cr it added the year before. Share price after the results: −9.5% in 30 days (Nifty 500: −7.8%).
  • Q2 FY26: Revenue ₹2,064 cr (+6% year on year), EBITDA ₹61.0 cr (−20% year on year), PAT ₹46.0 cr (−32% year on year), EBITDA margin 3.0% (−94 bps). Score 31 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 94 bps year on year. Other income 32% of PBT. Share price after the results: −10.2% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹1,861 cr (+9% year on year), EBITDA ₹16.0 cr (−72% year on year), PAT ₹8.0 cr (−70% year on year), EBITDA margin 0.9% (−247 bps). Score 23 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 247 bps year on year. Other income 167% of PBT. Tax rate -33%. Revenue fell 8% from last quarter. Revenue rose ₹151 cr on a year ago, against ₹425 cr the year before. Share price after the results: −0.1% in 29 days (Nifty 500: +1.5%).
  • Q4 FY25: Revenue ₹2,028 cr (+9% year on year), EBITDA ₹232 cr (+300% year on year), PAT ₹151 cr (−17% year on year), EBITDA margin 11.4% (+1,000 bps). Score 59 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA growth was well above it; profit growth was in line with it. EBITDA margin rose 1000 bps year on year. Revenue rose ₹172 cr on a year ago, against ₹460 cr the year before. Share price after the results: +3.4% in 30 days (Nifty 500: +0.8%).
  • Q3 FY25: Revenue ₹1,664 cr (+10% year on year), EBITDA −₹66.0 cr (−218% year on year), PAT −₹63.0 cr (−285% year on year), EBITDA margin -4.0% (−767 bps). Score 20 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 767 bps year on year. Revenue fell 15% from last quarter. Revenue rose ₹153 cr on a year ago, against ₹346 cr the year before.

Past price moves after results do not indicate future moves. Not a recommendation.

Religare Enterprises Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.